Portfolio Companies
Positron
Positron is a leading developer, manufacturer and distributor of cost
effective molecular imaging devices, radiopharmaceutical-dispensing
technologies, radiopharmaceuticals and unique heart disease management
programs to hospitals, medical centers, pharmacies, clinics, physicians
and other healthcare providers. Positron provides support and service
to nearly 150 clients throughout the world. Positron’s products
are focused in two segments of the nuclear medicine field; radiopharmaceutical
delivery molecular imaging devices. Positron is introducing a total
customer solution unique to the industry that will include a first to
market model for the distributions of radiopharmaceuticals. This breakthrough
will set a new industry standard.
Website: www.positron.com
Bio-Nucleonics
Bio-Nucleonics, Inc. is a privately held Florida corporation that
develops, manufactures and markets generic radiopharmaceuticals, medical
devices and imaging agents. Bio-Nucleonics is one of the few U.S.
based firms developing generic versions of these specialized therapeutic
and diagnostic products that are then sold to radio-pharmacies, hospitals
and free-standing imaging centers. The number of companies engaged
in production of radiopharmaceuticals is limited because of formidable
barriers of entry including multifaceted technical requirements, specialized
expertise, tightening regulatory environment and complex logistics.
Bio-Nucleonics has successfully overcome these challenges and is strategically
positioned to be on the market within twelve to eighteen months facing
limited competition. The Company has a reputation for excellence in
customer service, delivering consistent quality, no product recalls,
reliable on time delivery and competitive pricing. Competitive pricing
in this market is achieved since generics do not require human trials,
mitigating cost and time to market.
Website: www.bionucleonics.com
Zina Eva
Zina Eva is an early-stage development company with two divisions, originally established to
take advantage of the booming $60 billion a year Handbag Industry. The company
manufactures stylish high quality ladies handbags from the finest quality Italian lamb leather and
deer skin. In just one year of full operation, the company was already profitable, has no debt,
has opened over 600 accounts and is on the path to becoming a $50 million company within the
next four to five years. The products are sold wholesale to specialty stores such as Nordstrom’s
and boutiques at prices significantly below comparable brands.
Zina Eva’s newest division, Zindigo, has the first viral platform to turn social network users into
selling partners for the fashion industry. Consumers will no longer search for products, as
products will find consumers via social media. Every day, hundreds of millions of people use
social media to chat, share meaningful information and build relationships. They are talking
about their favorite brands and making recommendations to their friends. Every brand on the
planet is striving to figure out how to leverage the viral power of social networks. Zindigo has the
answer.
Website: www.zinaeva.com
